Literature DB >> 32423578

Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].

Yongshi Yang1, Fujun Peng2, Runsheng Wang3, Ming Yang4, Kai Guan1, Taijiao Jiang5, Guogang Xu6, Jinlyu Sun7, Christopher Chang8.   

Abstract

Entities:  

Year:  2020        PMID： 32423578      PMCID： PMC7228720          DOI： 10.1016/j.jaut.2020.102487

Source DB:  PubMed          Journal:  J Autoimmun        ISSN： 0896-8411            Impact factor:   7.094


× No keyword cloud information.
The authors would like to inform the readers that an error was made in the original article and one of the authors, Dr. Ming Yang was omitted. Ming Yange,* e. Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China. The authors wish to apologise for any inconvenience caused.
  22 in total

1.  Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?

Authors:  Xue Xing; Yi Yang; Jia Shi; Anying Cheng; Yanan Wang; Gang Xu; Fan He
Journal:  Nefrologia (Engl Ed)       Date:  2020-09-29

2.  Risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke: A retrospective study of 380 patients from a rehabilitation hospital: A retrospective study of risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke.

Authors:  Jia Xu; Zhiling Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

Review 3.  Natural product-derived phytochemicals as potential agents against coronaviruses: A review.

Authors:  Janice S Mani; Joel B Johnson; Jason C Steel; Daniel A Broszczak; Paul M Neilsen; Kerry B Walsh; Mani Naiker
Journal:  Virus Res       Date:  2020-04-30       Impact factor: 3.303

Review 4.  High-throughput screening assays for SARS-CoV-2 drug development: current status and future directions.

Authors:  Tuan Xu; Wei Zheng; Ruili Huang
Journal:  Drug Discov Today       Date:  2021-05-25       Impact factor: 7.851

Review 5.  Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review.

Authors:  Humna Sajjad; Mohsin Majeed; Saiqa Imtiaz; Mariyam Siddiqah; Anila Sajjad; Misbahud Din; Muhammad Ali
Journal:  Biologia (Bratisl)       Date:  2021-06-02       Impact factor: 1.653

6.  Mental health outcomes of ICU and non-ICU healthcare workers during the COVID-19 outbreak: a cross-sectional study.

Authors:  Sara Cereghetti; Hannah Wozniak; Lamyae Benzakour; Grégory Moullec; Niccolò Buetti; Alice Nguyen; Sandrine Corbaz; Pauline Roos; Laure Vieux; Jean-Claude Suard; Rafaël Weissbrodt; Jérôme Pugin; Jacques A Pralong
Journal:  Ann Intensive Care       Date:  2021-07-10       Impact factor: 6.925

7.  A Correlation Analysis between the Nutritional Status and Prognosis of COVID-19 Patients.

Authors:  J Zhou; Y Ma; Y Liu; Y Xiang; C Tao; H Yu; J Huang
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

Review 8.  Novel Coronavirus International Public Health Emergency: Guidance on Radiation Oncology Facility Operation.

Authors:  Wei Chen; Xiao-Ye Su; Victoria J Wang; Edina C Wang; Ruizhen Xu; Shiyan Zhong; Guoping Sun; Jun Xia
Journal:  Adv Radiat Oncol       Date:  2020-04-01

Review 9.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.

Authors:  Wei Feng; Wei Zong; Feng Wang; Shaoqing Ju
Journal:  Mol Cancer       Date:  2020-06-02       Impact factor: 41.444

10.  Diacerein: A potential multi-target therapeutic drug for COVID-19.

Authors:  Pedro Gonçalves de Oliveira; Lara Termini; Edison Luiz Durigon; Ana Paula Lepique; Andrei C Sposito; Enrique Boccardo
Journal:  Med Hypotheses       Date:  2020-06-01       Impact factor: 1.538
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.